JSM2026
Back to all people

Kerstine Carter

Boehringer Ingelheim Pharmaceuticals, Inc.
2 appearances in the program

Sessions & presentations

Rethinking Randomization: Bias, Ethics, and the Future of Clinical Trial Design.
Invited Paper Session · Sun, Aug 2 , 2:00 PM
Organizer
Rethinking Randomization: Bias, Ethics, and the Future of Clinical Trial Design.
Presentation: Forced Randomization in Clinical Trials: A look at its impact on patient and analysis.
Invited Paper Session · Sun, Aug 2 , 2:00 PM
Speaker
↑